Clinical Trial Update: Neuroendocrine Brake for Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a neuroendocrine brake for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Neuroendocrine Brake

Snippet

Sponsor: Medtronic - MITG | Conditions: Diabetes | Phase 4 | Status: COMPLETED